GoalVest Advisory’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.1K Sell
358
-362
-50% -$100K 0.01% 174
2026
Q1
$213K Buy
720
+18
+3% +$5.35K 0.04% 144
2025
Q4
$192K Buy
702
+263
+60% +$71.5K 0.04% 149
2025
Q3
$119K Hold
439
0.03% 160
2025
Q2
$121K Buy
439
+177
+68% +$48.1K 0.03% 157
2025
Q1
$69.5K Buy
262
+101
+63% +$24.9K 0.02% 161
2024
Q4
$37.4K Hold
161
0.01% 202
2024
Q3
$35.5K Buy
161
+111
+222% +$23K 0.01% 218
2024
Q2
$9.83K Sell
50
-85
-63% -$17.6K ﹤0.01% 276
2024
Q1
$29.1K Sell
135
-65
-33% -$13.7K 0.01% 233
2023
Q4
$42.1K Buy
200
+185
+1,233% +$39.5K 0.02% 148
2023
Q3
$3K Buy
+15
New +$2.98K ﹤0.01% 389
2023
Q2
Sell
-60
Closed -$11.5K 370
2023
Q1
$11.5K Hold
60
0.01% 182
2022
Q4
$10.1K Hold
60
0.01% 183
2022
Q3
$11K Hold
60
0.01% 181
2022
Q2
$12K Hold
60
0.01% 247
2022
Q1
$14K Buy
+60
New +$14.1K 0.01% 217
2021
Q1
Sell
-60
Closed -$11K 180
2020
Q4
$11K Buy
+60
New +$10.2K 0.01% 164

Other funds holding CME

GoalVest Advisory's CME Position: Q2 2026 in Review

GoalVest Advisory reduced its CME Group (CME) stake by 50% in Q2 2026, selling an estimated $100K and leaving 358 shares worth $79.1K. The position accounts for 0.01% of the portfolio, ranked #174.

GoalVest Advisory first reported a position in CME in Q4 2020 and has held it in 18 quarters since. The position peaked at $213K in Q1 2026. 216 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • GoalVest Advisory held 358 shares of CME Group worth $79.1K as of Q2 2026.
  • GoalVest Advisory sold 362 CME Group shares in Q2 2026, an estimated $100K.
  • CME Group made up 0.01% of GoalVest Advisory's portfolio in Q2 2026, its #174 holding.
  • GoalVest Advisory first reported a position in CME Group in Q4 2020 and has held it in 18 quarters since.
  • GoalVest Advisory's CME Group position peaked at $213K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on GoalVest Advisory's 13F filing for Q2 2026, filed 9 Jul 2026.